Search results

401. Environmental and epigenetic modifications and atopy and allergic diseases prevention in rural population at all ages - …

Principal investigator: dr hab. Barbara Ewa Sozańska

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: OPUS 24, Panel: NZ7

402. Brain-targeted β‐hydroxy-β‐methylbutyrate administration in the prevention of insulin resistance development in the hypo…

Principal investigator: dr Elżbieta Supruniuk

Uniwersytet Medyczny w Białymstoku

Call: SONATA 18, Panel: NZ7

403. Assessment of the ability of Mycobacterium bovis BCG-onko bacilli to control the development of Helicobacter pylori infe…

Principal investigator: dr Weronika Gonciarz

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: SONATA 18, Panel: NZ7

404. The effect of maternal treatment with metformin in pregnancy and lactation on programming metabolic adverse conditions i…

Principal investigator: dr hab. Monika Słupecka-Ziemilska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA BIS 12, Panel: NZ7

405. A smart stride for cancer: synergistic effect of co-delivery chemo- andphototherapeutic agents using magneto-fluorescent…

Principal investigator: dr Prachi Uttam Ghoderao

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: POLONEZ BIS 2, Panel: NZ7

406. The effect of glyphosate exposure on morphology, innervation and contractility of the uterus in sexually immature gilts.

Principal investigator: Aleksandra Angelika Karpiesiuk

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Medycyny Weterynaryjnej

Call: PRELUDIUM 21, Panel: NZ7

407. Searching for natural bioactive farnesoid X receptor agonists and their role in parenteral nutrition-associated liver di…

Principal investigator: dr hab. Maciej Jan Stawny

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 23, Panel: NZ7

408. Studies on the post-receptor mechanisms of TSPO in search of a novel therapeutic target of metabolic syndrome

Principal investigator: dr Łukasz Kurach

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 21, Panel: NZ7

409. NanoSens: Towards multi-evidence approach for the risk assessment of a diverse group of nanoparticles and advanced mater…

Principal investigator: dr Kabiruddin Ikramuddin Khan

Uniwersytet Gdański, Wydział Chemii

Call: POLONEZ BIS 2, Panel: NZ7

410. Flexible, stretchable and antibacterial curdlan-tannin dressing for the prevention and treatment of infected wounds - in…

Principal investigator: dr Anna Maria Michalicha

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 21, Panel: NZ7

411. The assessment of purity and identity confirmation of extracellular vesicles withcapillary electrophoresis

Principal investigator: Aleksandra Steć

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 21, Panel: NZ7

412. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu…

Principal investigator: prof. Władysława Anna Daniel

Instytut Farmakologii PAN

Call: OPUS 23, Panel: NZ7

413. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

Principal investigator: Dawid Dariusz Dorna

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 21, Panel: NZ7

414. Evaluation of butterbur (Petasites spp) for the antimigraine potential: Isolation of bioactive secondary metabolites (pe…

Principal investigator: Łukasz Dawid Kulinowski

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 21, Panel: NZ7

415. Smart tissue engineering to change the paradigm of diabetes treatment

Principal investigator: dr Anna Czarna

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Call: OPUS 23, Panel: NZ7

416. Bionanoparticles with a molecular targeting device as a weapon for breast cancer

Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

Uniwersytet Gdański, Wydział Chemii

Call: OPUS 23, Panel: NZ7

417. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Call: OPUS 23, Panel: NZ7

418. Associations between Babesia, Borrelia and Theileria and tick vectors in different ecosystems of the world

Principal investigator: prof. Anna - Bajer

Uniwersytet Warszawski, Wydział Biologii

Call: OPUS 23, Panel: NZ7

419. Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies…

Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

Instytut Chemii Bioorganicznej PAN

Call: OPUS 23, Panel: NZ7

420. Analysis of the influence of microplastic (polyethylene terephthalate, PET) on transcriptomic profile of the liver and i…

Principal investigator: Monika Golubska

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

Call: PRELUDIUM 21, Panel: NZ7

421. Role of natural products in overcoming drug resistance in Mycobacterium tuberculosis

Principal investigator: dr Elwira Zofia Sieniawska

Uniwersytet Medyczny w Lublinie

Call: OPUS 23, Panel: NZ7

422. Effect of liraglutide on inflammatory response of peripheral blood mononuclear cells (PBMCs) in subjects at risk of type…

Principal investigator: Marta Dobrzycka

Uniwersytet Medyczny w Białymstoku

Call: PRELUDIUM 21, Panel: NZ7

423. Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and bias…

Principal investigator: prof. Sławomir Hubert Filipek

Uniwersytet Warszawski, Wydział Chemii

Call: OPUS 23, Panel: NZ7

424. Understanding drug/polymer/plasticizer miscibility and its effect on mechanical properties of polymeric filaments for FD…

Principal investigator: Marta Maria Kozakiewicz-Latała

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: PRELUDIUM 21, Panel: NZ7

425. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi…

Principal investigator: prof. Krzysztof Tomasz Kamiński

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 23, Panel: NZ7

426. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

Principal investigator: Karolina Barbara Przepiórska-Drońska

Instytut Farmakologii PAN

Call: PRELUDIUM 21, Panel: NZ7

427. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud…

Principal investigator: dr Magdalena Białoń

Instytut Farmakologii PAN

Call: PRELUDIUM 21, Panel: NZ7

428. A comprehensive approach to powders for pharmaceutical 3D printing using Selective Laser Sintering - development of stra…

Principal investigator: dr hab. Piotr Paweł Kulinowski

Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie

Call: OPUS 23, Panel: NZ7

429. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D…

Principal investigator: Kinga Maria Czarnota-Łydka

Uniwersytet Jagielloński, Collegium Medicum

Call: PRELUDIUM 21, Panel: NZ7

430. Effects of activation of cholinergic, noradrenergic, and serotonergic systems on respiratory impairment in Alzheimer's d…

Principal investigator: prof. Katarzyna Kaczyńska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 23, Panel: NZ7

431. Reserved antibiotics and critical priority pathogens in hospital wastewater as an indicator of sanitary-epidemiological …

Principal investigator: prof. Ewa Korzeniewska

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: OPUS 23, Panel: NZ7

432. Extracellular vesicles modifications for future drug delivery systems

Principal investigator: prof. Ewa Łucja Stępień

Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

Call: OPUS 23, Panel: NZ7

433. Modulating effect of elicitors on the biosynthesis of bioactive metabolites in Nigella damascena in vitro cultures - A t…

Principal investigator: dr Magdalena Klimek-Chodacka

Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Biotechnologii i Ogrodnictwa

Call: OPUS 23, Panel: NZ7

434. Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding …

Principal investigator: Anna Nowak-Szwed

Warszawski Uniwersytet Medyczny

Call: PRELUDIUM 21, Panel: NZ7

435. The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free …

Principal investigator: Maciej Spiegel

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

Call: PRELUDIUM 21, Panel: NZ7

436. PFAS exposure and premature ovarian insufficiency: molecular mechanism.

Principal investigator: dr hab. Anna Ptak

Uniwersytet Jagielloński, Wydział Biologii

Call: OPUS 23, Panel: NZ7

437. The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechan…

Principal investigator: Agnieszka Magdalena Woźniak

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: PRELUDIUM 21, Panel: NZ7

438. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st…

Principal investigator: dr Bartłomiej Pochwat

Instytut Farmakologii PAN

Call: SONATA 17, Panel: NZ7

439. ECbiome genotyping and assessment of its involvement in pathogenic processes of endometrial cancer development

Principal investigator: dr Aleksandra Maria Kowalczyk

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: SONATA 17, Panel: NZ7

440. The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i…

Principal investigator: dr Magdalena Olbryt

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 22, Panel: NZ7

441. Two-component preparations in the treatment of infections caused by pathogenic microorganisms

Principal investigator: dr Katarzyna Szałapata

Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

Call: SONATA 17, Panel: NZ7

442. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced…

Principal investigator: dr hab. Maciej Antoni Wnuk

Uniwersytet Rzeszowski, Collegium Medicum

Call: OPUS 22, Panel: NZ7

443. Cognitive impairment in chronic pain - CBD as the undervalued remedy.

Principal investigator: prof. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

Call: OPUS 22, Panel: NZ7

444. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

Principal investigator: dr Tadeusz Piotr Karcz

Uniwersytet Jagielloński, Collegium Medicum

Call: SONATA 17, Panel: NZ7

445. The influence of microplastic on the functions of the HPG and HPA endocrine axes in immature gilts - in vivo studies

Principal investigator: prof. Iwona Urszula Bogacka

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

Call: OPUS 22, Panel: NZ7

446. MOF-antidote": Novel detoxification materials based on metal organic-frameworks for drugs of abuse removal - synthesis, …

Principal investigator: dr hab. Przemysław Jakub Jodłowski

Politechnika Krakowska im. Tadeusza Kościuszki

Call: OPUS 22, Panel: NZ7

447. Biological roles of transcriptional networks activated in the brain by psychotropic drugs

Principal investigator: dr hab. Michał Korostyński

Instytut Farmakologii PAN

Call: PRELUDIUM BIS 3, Panel: NZ7

448. Bifunctional, pH-responsive zeolite-bisphosphonates complex as a base for the production of smart bone implant for osteo…

Principal investigator: prof. Agata Natalia Przekora-Kuśmierz

Uniwersytet Medyczny w Lublinie, Wydział Nauk Medycznych

Call: OPUS 22, Panel: NZ7

449. Chemo-enzymatic synthesis of dihydrochalcones glycosides and their health promoting activity

Principal investigator: dr hab. Tomasz Janeczko

Uniwersytet Przyrodniczy we Wrocławiu

Call: PRELUDIUM BIS 3, Panel: NZ7

450. Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer

Principal investigator: dr Katarzyna Magiera-Mularz

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 22, Panel: NZ7

Projects search